WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2 "WAVECREST2"

Recruiting

Phase 3 Results N/A

Summary of Purpose

The WAVECREST 2 trial is a prospective, multicenter, randomized, active controlled, clinical trial to evaluate the safety and effectiveness of the Coherex WaveCrest Left Atrial Appendage (LAA) Occlusion System.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 17 January 2018.

28 Dec 2017 29 Sep 2017 1 Dec 2020 1 Dec 2025 1 Jan 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts